LOCUS       BAD01717                1214 aa            linear   PLN 16-FEB-2008
DEFINITION  putative brassinosteroid receptor [Oryza sativa Japonica Group].
ACCESSION   BAD01717
VERSION     BAD01717.1  GI:38423989
DBSOURCE    accession AP004553.2
KEYWORDS    .
SOURCE      Oryza sativa Japonica Group (Japanese rice)
  ORGANISM  Oryza sativa Japonica Group
            Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
            Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BEP
            clade; Ehrhartoideae; Oryzeae; Oryza.
REFERENCE   1
  AUTHORS   Sasaki,T., Matsumoto,T. and Yamamoto,K.
  TITLE     Oryza sativa nipponbare(GA3) genomic DNA, chromosome 8, BAC
            clone:OJ1790_D02
  JOURNAL   Published Only in Database (2001)
REFERENCE   2  (residues 1 to 1214)
  AUTHORS   Sasaki,T., Matsumoto,T. and Yamamoto,K.
  TITLE     Direct Submission
  JOURNAL   Submitted (19-DEC-2001) Contact:Takuji Sasaki National Institute of
            Agrobiological Sciences, Rice Genome Research Program; Kannondai
            2-1-2, Tsukuba, Ibaraki 305-8602, Japan URL
            :http://rgp.dna.affrc.go.jp/
COMMENT     Genes were predicted from the integrated results of the following:
            GENSCAN (http://CCR-081.mit.edu/GENSCAN.html), FGENESH
            (http://www.softberry.com/), GeneMark.hmm
            (http://opal.biology.gatech.edu/GeneMark/), GlimmerM
            (http://www.tigr.org/tdb/glimmerm/glmr_form.html), RiceHMM
            (http://rgp.dna.affrc.go.jp/RiceHMM/), SplicePredictor
            (http://bioinformatics.iastate.edu/cgi-bin/sp.cgi), sim4
            (http://globin.cse.psu.edu/html/docs/sim4.html), gap2
            (http://www.tigr.org/software/glimmerm/), BLASTN and BLASTX. The
            genomic sequence was searched against NCBI NonRedundant Protein
            database, nr (ftp://ncbi.nlm.nih.gov/blast/db) and the cDNA
            sequence database at RGP or DDBJ. Protein homologies of the coding
            regions were searched against NCBI NonRedundant Protein database
            with BLASTP. ESTs represent the identified cDNA sequences using
            BLASTN with the corresponding DDBJ accession no. and RGP clone ID.
            Full-length cDNAs represent the identified cDNA sequences using
            BLASTN with the corresponding DDBJ accession no.
            A gene with identity or significant homology to a protein is
            classified based on the protein name to indicate the homology level
            such as same name, 'putative-' and '-like protein'.  A gene without
            significant homology to any protein but with full-length cDNA or
            EST homology (covering almost the entire length of partial
            sequence) is classified as an 'unknown' protein. A gene predicted
            by two or more gene prediction programs is classified as a
            'hypothetical' protein according to IRGSP standard. A gene
            predicted by a single gene prediction program is also classified as
            a probable 'hypothetical' protein and is included as a
            miscellaneous feature of the sequence.
            The orientation of the sequence is from -21M13 to M13rev of the BAC
            clone. This sequence of OJ1790_D02 clone has an overlap with
            OSJNBa0062G05 (DDBJ: AP005491) clone at 5' end and with OJ1119_B10
            (DDBJ: AP004645) at 3' end. The sequence was generated by combining
            Monsanto and RGP-Japan sequencing data. Detailed information on
            overlap and assembly quality together with annotation of this entry
            is available at
            http://rgp.dna.affrc.go.jp/GenomeSeq.html.
FEATURES             Location/Qualifiers
     source          1..1214
                     /organism="Oryza sativa Japonica Group"
                     /cultivar="Nipponbare"
                     /db_xref="taxon:39947"
                     /chromosome="8"
                     /clone="OJ1790_D02"
     Protein         1..1214
                     /product="putative brassinosteroid receptor"
     Region          <43..76
                     /region_name="LRRNT_2"
                     /note="Leucine rich repeat N-terminal domain; pfam08263"
                     /db_xref="CDD:254692"
     Region          158..216
                     /region_name="LRR_8"
                     /note="Leucine rich repeat; pfam13855"
                     /db_xref="CDD:258126"
     Region          159..452
                     /region_name="LRR_RI"
                     /note="Leucine-rich repeats (LRRs), ribonuclease inhibitor
                     (RI)-like subfamily. LRRs are 20-29 residue sequence
                     motifs present in many proteins that participate in
                     protein-protein interactions and have different functions
                     and cellular locations. LRRs correspond...; cd00116"
                     /db_xref="CDD:238064"
     Site            order(159,162,164,167,169,180,183,185,188,190,206,209,211,
                     214,216,232,234,237,239,280,283,285,288,290,305,308,310,
                     313,315,330,333,335,338,340,379,382,384,387,389,404,407,
                     409,412,414,430,433,435,438,440)
                     /site_type="other"
                     /note="Leucine-rich repeats"
                     /db_xref="CDD:238064"
     Site            order(165..166,213,287,312,386,408,410,434)
                     /site_type="other"
                     /note="Substrate binding site [chemical binding]"
                     /db_xref="CDD:238064"
     Region          254..315
                     /region_name="LRR_8"
                     /note="Leucine rich repeat; pfam13855"
                     /db_xref="CDD:258126"
     Region          353..563
                     /region_name="LRR_RI"
                     /note="Leucine-rich repeats (LRRs), ribonuclease inhibitor
                     (RI)-like subfamily. LRRs are 20-29 residue sequence
                     motifs present in many proteins that participate in
                     protein-protein interactions and have different functions
                     and cellular locations. LRRs correspond...; cd00116"
                     /db_xref="CDD:238064"
     Site            order(355,358,360,363,365,379,382,384,387,389,404,407,409,
                     413,415,430,433,435,438,440,455,458,460,463,465,479,482,
                     484,487,489,503,506,508,511,513,528,531,533,536,538,552,
                     555,557,560,562)
                     /site_type="other"
                     /note="Leucine-rich repeats"
                     /db_xref="CDD:238064"
     Region          355..414
                     /region_name="LRR_8"
                     /note="Leucine rich repeat; pfam13855"
                     /db_xref="CDD:258126"
     Site            order(386,437,462,510,532,534,556)
                     /site_type="other"
                     /note="Substrate binding site [chemical binding]"
                     /db_xref="CDD:238064"
     Region          428..489
                     /region_name="LRR_8"
                     /note="Leucine rich repeat; pfam13855"
                     /db_xref="CDD:258126"
     Region          502..562
                     /region_name="LRR_8"
                     /note="Leucine rich repeat; pfam13855"
                     /db_xref="CDD:258126"
     Region          551..610
                     /region_name="LRR_8"
                     /note="Leucine rich repeat; pfam13855"
                     /db_xref="CDD:258126"
     Region          695..750
                     /region_name="LRR_8"
                     /note="Leucine rich repeat; pfam13855"
                     /db_xref="CDD:258126"
     Region          919..1184
                     /region_name="STYKc"
                     /note="Protein kinase; unclassified specificity;
                     smart00221"
                     /db_xref="CDD:214568"
     Region          919..1180
                     /region_name="PKc_like"
                     /note="Protein Kinases, catalytic domain; cl09925"
                     /db_xref="CDD:263920"
     Site            order(919..923,927,939,941,970,986..989,993,995,1039,1041,
                     1043..1044,1046,1057,1060,1083..1084)
                     /site_type="active"
                     /db_xref="CDD:173623"
     Site            order(919..923,927,939,941,970,986..989,993,1039,1041,
                     1043..1044,1046,1057)
                     /site_type="other"
                     /note="ATP binding site [chemical binding]"
                     /db_xref="CDD:173623"
     Site            order(923,993,995,1039,1041,1043,1060,1083..1084)
                     /site_type="other"
                     /note="substrate binding site [chemical binding]"
                     /db_xref="CDD:173623"
     Site            order(1056..1062,1083..1084)
                     /site_type="other"
                     /note="activation loop (A-loop)"
                     /db_xref="CDD:173623"
     CDS             1..1214
                     /gene="OJ1790_D02.27"
                     /coded_by="complement(AP004553.2:109973..113617)"
ORIGIN      
        1 maavrvvapa psvlllvaaa vvllhlarai agaadeaaal lafkdasvaa dpggalagwa
       61 nsttpgspca wagvscaagr vraldlsgms lsgrlrldal lalsalrrld lrgnafhgdl
      121 srhgsprraa pcalvevdis sntfngtlpr aflascgglq tlnlsrnslt gggypfppsl
      181 rrldmsrnql sdagllnysl tgchgiqyln lsanqftgsl pglapctevs vldlswnlms
      241 gvlpprfvam apanltylsi agnnfsmdis dyefggcanl tlldwsynrl rstglprslv
      301 dcrrlealdm sgnkllsgpi ptflvelqal rrlslagnrf tgeisdklsi lcktlveldl
      361 ssnqligslp asfgqcrflq vldlgnnqls gdfvetvitn isslrvlrlp fnnitganpl
      421 palasrcpll evidlgsnef dgeimpdlcs slpslrklll pnnyingtvp sslsncvnle
      481 sidlsfnllv gqippeilfl lklvdlvlwa nnlsgeipdk fcfnstalet lvisynsftg
      541 nipesitrcv nliwlslagn nltgsipsgf gnlqnlailq lnknslsgkv paelgscsnl
      601 iwldlnsnel tgtippqlaa qaglitgaiv sgkqfaflrn eagnicpgag vlfefldirp
      661 drlanfpavh lcsstriytg ttvytfrnng smifldlsyn sltgtipasf gnmtylevln
      721 lghneltgai pdaftglkgi galdlshnhl tgvippgfgc lhfladfdvs nnnltgeipt
      781 sgqlitfpas ryennsglcg iplnpcvhns gagglpqtsy ghrnfarqsv flavtlsvli
      841 lfslliihyk lwkfhknktk eiqagcsesl pgssksswkl sgigeplsin maifenplrk
      901 ltfsdlhqat ngfcaetlig sggfgevyka klkdgnivav kklmhftgqg dreftaemet
      961 igkikhrnlv pllgyckigd erllvyeymk ngsldfvlhd kgeanmdlnw atrkkiaigs
     1021 arglaflhhs cvphiihrdm kssnvlldgn fdayvsdfgm arlmnaldsh ltvsmlsgtp
     1081 gyvppeycqd frcttkgdvy sygvvllell tgkkpidpte fgdsnlvgwv kqmvedrcse
     1141 iydptlmatt sselelyqyl kiacrclddq pnrrptmiqv mtmfkefqvd sgsnflddfs
     1201 lnstnmeess eksv
//

